Corrigendum to "A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance" [Genes Dis 694 (2019) 419-430]

Genes Dis. 2019 Dec 28;7(1):160-161. doi: 10.1016/j.gendis.2019.12.006. eCollection 2020 Mar.

Authors

Wei Wang^{1

2}, Bo Hu^{3

4}, Jiang-Jiang Qin¹, Jianwen Cheng^{3

4}, Xin Li¹, Mehrdad Rajaei¹, Jia Fan^{3

4}, Xin-Rong Yang^{3

4}, Ruiwen Zhang^{1

2}

Affiliations

¹ Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, 77204, USA.
² Drug Discovery Institute, University of Houston, Houston, TX, 77204, USA.
³ Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
⁴ Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai, 200032, China.

Abstract

[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].

© 2019 Chongqing Medical University. Production and hosting by Elsevier B.V. All rights reserved.

Publication types

Published Erratum